1. Home
  2. HKIT vs CTSO Comparison

HKIT vs CTSO Comparison

Compare HKIT & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HKIT

Hitek Global Inc.

N/A

Current Price

$2.61

Market Cap

28.3M

Sector

Technology

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$4.19

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HKIT
CTSO
Founded
1996
1997
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
23.9M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
HKIT
CTSO
Price
$2.61
$4.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.1K
★ 335.4K
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.79
EPS
★ N/A
N/A
Revenue
N/A
★ $22,503,908.00
Revenue This Year
N/A
$4.91
Revenue Next Year
N/A
$13.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$0.03
$0.30
52 Week High
$8.80
$7.44

Technical Indicators

Market Signals
Indicator
HKIT
CTSO
Relative Strength Index (RSI) 48.88 52.25
Support Level $2.34 $0.47
Resistance Level $2.98 $7.44
Average True Range (ATR) 0.25 0.54
MACD 0.02 -0.33
Stochastic Oscillator 50.77 4.74

Price Performance

Historical Comparison
HKIT
CTSO

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of business services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from Hardware and equipment sales, Tax services, and Software sales.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: